The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Xiros sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Xiros Ltd (Xiros) is a company that manufactures medical equipment. It designs, develops and supplies implantable textile-based scaffolds for ligament, tendon and soft tissue injuries. The company’s products include rota-lok implant system and leeds-kuff patch permanent implant for shoulder; patellartape implant system and hybrid implant system for knee. It offers peroneal tendon with poly-tape and achillocordplus implant system for foot and poly-tapes. The company also carries out research, design, development, manufacture and marketing its devices medical industries. The company markets the products under the brand name Neoligaments. It operates through a network of distributors in Africa, Australia, Europe, Middle East and North America. Xiros is headquartered in Leeds, Greater London, The UK.
The key metrics of Xiros related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Xiros is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Xiros.
For a detailed understanding of the performance of Xiros, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
